Insecticides (India) Limited reported a significant decline in profitability for the quarter ended June 30, 2026, with standalone net profit falling 27% year-on-year to ₹4,183.05 million. The downturn was mirrored in consolidated figures, where net profit attributable to owners dropped 24% to ₹4,387.44 million, signaling pressure across the group's agro-chemical operations due to lower sales volumes and margin compression.

The Board of Directors approved the unaudited financial results on August 11, 2026, following a review by the Audit Committee. The results were subjected to a limited review by joint statutory auditors S S Kothari Mehta & Co., LLP and Devesh Parekh & Co., in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Overview

Revenue from operations declined for both standalone and consolidated entities compared to the same period in FY25. Standalone revenue fell 11% to ₹61,648.22 million from ₹69,137.24 million, while consolidated revenue dropped similarly to ₹61,152.31 million from ₹69,113.31 million. This top-line contraction directly impacted bottom-line results, despite relatively stable cost structures.

Operating profitability also weakened during the quarter. Standalone EBITDA declined to ₹659 million from ₹840 million in the same period last year. The EBITDA margin contracted to 10.90% from 12.15% year-on-year, reflecting the combined impact of lower revenues and a relatively less flexible cost base during the period.

What the Numbers Show

The divergence between revenue decline and profit contraction highlights margin compression. While cost of materials consumed remained relatively flat at ₹38,641.98 million standalone versus ₹38,763.70 million last year, the reduction in revenue volume meant fixed costs like employee benefits (₹4,498.34 million vs ₹4,105.82 million) and other expenses (₹7,638.91 million vs ₹7,507.92 million) weighed more heavily on margins. This suggests operational inefficiencies or inability to pass on cost pressures during a period of reduced demand.

Additionally, the company continues its structural cleanup, having received approval for the dissolution of its wholly owned subsidiary IIL Overseas DMCC, Dubai, on September 19, 2025. This move aims to streamline operations, though its financial impact remains minimal in the current quarter.

Insecticides (India) Limited will announce its Standalone and Consolidated Unaudited Financial results for the quarter ended June 30, 2026, on August 11, 2026. The company has scheduled an earnings conference call at 5:00 PM IST on the same day to discuss the Q1 FY27 financial results with stakeholders.

The conference call will feature key executives from the company, including Mr. Rajesh Kumar Aggarwal, Managing Director, Mr. Sandeep Kumar Aggarwal, Chief Financial Officer, Mr. Devendra Kumar Ray, Chief Operating Officer, and Mr. Dushyant Sood, Chief Marketing Officer. The leadership team will address queries regarding the quarterly performance.

Conference Call Details

The event provides an opportunity for investors and analysts to gain insights into the company's operational and financial metrics for the first quarter of FY27. Participants can join the discussion via the provided domestic and international access numbers.

For further information regarding the conference call, stakeholders may contact Mr. Nikunj Seth or Ms. Sejal Bhattar at +91 9773397958 or +91 7666736666.